IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients

被引:1
|
作者
Mauricio Venegas [1 ]
Rodrigo A Villanueva [2 ]
Katherine González [1 ]
Javier Brahm [1 ]
机构
[1] Centro de Estudios Avanzados de las Hepatitis Virales,Sección de Gastroenterología,Departamento de Medicina,Hospital Clínico Universidad de Chile
[2] Centro de Estudios Avanzados de las Hepatitis Virales,Laboratorio de Virus Hepatitis,Programa de Virología,Instituto de Ciencias Biomédicas,Facultad de Medicina,Universidad de Chile
关键词
IL28B; Hepatitis C virus; Chile; Pegylated interferon; Ribavirin;
D O I
暂无
中图分类号
R512.63 [];
学科分类号
100401 ;
摘要
AIM:To analyze the association of three IL28B single nucleotide polymorphisms with response to therapy in Chilean patients infected with hepatitis C virus CV.METHODS:We studied two groups of patients with chronic CV infection genotype 1,under standard combined treatment with pegylated interferon plus ribavirin.One group consisted of 50 patients with sustained virological response,whereas the second group consisted of 49 null responders.In order to analyze the IL28B single nucleotide polymorphisms rs12979860,rs12980275 and rs8099917,samples were used for polymerase chain reaction amplification,and the genotyping was performed by restriction fragment lengthpolymorphism.RESULTS:The IL28B rs12979860 CC,rs12980275 AA and rs8099917 TT genotypes were much more frequently found in patients with sustained virological response compared to null responders 38%,44% and 50% vs 2%,8.2% and 8.2%,respectively.These differences were highly significant in all three cases(P < 0.0001.CONCLUSION:The three IL28B polymorphisms studied are strongly associated with sustained virological response to therapy in Chilean patients with chronic CV genotype 1.
引用
收藏
页码:3636 / 3639
页数:4
相关论文
共 50 条
  • [1] IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients
    Venegas, Mauricio
    Villanueva, Rodrigo A.
    Gonzalez, Katherine
    Brahm, Javier
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (31) : 3636 - 3639
  • [2] The influence of IL28B polymorphisms on treatment response in patients with chronic hepatitis C
    Svorcan, Petar
    Lazarevic, Ivana
    Delic, Dragan
    Jovanovic, Tanja
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 206 - 206
  • [3] IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4
    Antaki, N.
    Bibert, S.
    Kebbewar, K.
    Asaad, F.
    Baroudi, O.
    Alideeb, S.
    Hadad, M.
    Abboud, D.
    Sabah, H.
    Bochud, P. -Y.
    Negro, F.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (01) : 59 - 64
  • [4] Investigation of the Relationship Between IL28B Polymorphisms and Plasma IL28B Levels in Patients with Chronic Hepatitis B or C
    Kuralay, Zeynep Koc
    Tug, Esra
    Fidan, Isil
    MIKROBIYOLOJI BULTENI, 2021, 55 (03): : 374 - 388
  • [5] IL28B polymorphisms and treatment of hepatitis C
    Clark P.J.
    Thompson A.J.V.
    Muir A.J.
    Current Hepatitis Reports, 2011, 10 (1) : 70 - 78
  • [6] Association of IL28B polymorphisms with virological response to peginterferon and ribavirin therapy in children and adolescents with chronic hepatitis C
    Tajiri, Hitoshi
    Tanaka, Yasuhito
    Takano, Tomoko
    Suzuki, Mitsuyoshi
    Abukawa, Daiki
    Miyoshi, Yoko
    Shimizu, Toshiaki
    Brooks, Stephen
    HEPATOLOGY RESEARCH, 2014, 44 (10) : E38 - E44
  • [7] The influence of single and combined IL28B polymorphisms on response to treatment of chronic hepatitis C
    Lazarevic, Ivana
    Djordjevic, Jelena
    Cupic, Maja
    Karalic, Danijela
    Delic, Dragan
    Svirtlih, Neda
    Simonovic, Jasmina
    Svorcan, Petar
    Milic, Natasa
    Jovanovic, Tanja
    JOURNAL OF CLINICAL VIROLOGY, 2013, 58 (01) : 254 - 257
  • [8] IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients
    Ohnishi, Mayu
    Tsuge, Masataka
    Kohno, Tomohiko
    Zhang, Yizhou
    Abe, Hiromi
    Hyogo, Hideyuki
    Kimura, Yuki
    Miki, Daiki
    Hiraga, Nobuhiko
    Imamura, Michio
    Takahashi, Shoichi
    Ochi, Hidenori
    Hayes, C. Nelson
    Tanaka, Shinji
    Arihiro, Koji
    Chayama, Kazuaki
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (07) : 834 - 844
  • [9] IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C
    Asselah, Tarik
    De Muynck, Simon
    Broet, Philippe
    Masliah-Planchon, Julien
    Blanluet, Maud
    Bieche, Ivan
    Lapalus, Martine
    Martinot-Peignoux, Michelle
    Lada, Olivier
    Estrabaud, Emilie
    Zhang, Qian
    El Ray, Ahmed
    Vidaud, Dominique
    Ripault, Marie-Pierre
    Boyer, Nathalie
    Bedossa, Pierre
    Valla, Dominique
    Vidaud, Michel
    Marcellin, Patrick
    JOURNAL OF HEPATOLOGY, 2012, 56 (03) : 527 - 532
  • [10] IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population
    Cavalcante, Lourianne N.
    Abe-Sandes, Kiyoko
    Angelo, Ana Luisa D.
    Machado, Taisa M. B.
    Lemaire, Denise C.
    Mendes, Carlos M. C.
    Pinho, Joao R.
    Malta, Fernanda
    Lyra, Luiz G. C.
    Lyra, Andre C.
    LIVER INTERNATIONAL, 2012, 32 (03) : 476 - 486